Our Macular Disease Conference 2025 was held on Saturday 13 September. Many of you joined us for our tailored session for people with inherited retinal diseases.

Missed the live session? You can now watch back all the talks from the Macular Disease Conference 2025. Hear from leading experts as they share the latest updates on treatments, research breakthroughs, and support for people living with inherited macular conditions.

Talks in this session

Welcome

Speaker: Ed Holloway, chief executive, Macular Society.

Description: Ed Holloway welcomes you to our 2025 Macular Disease Conference.

What are the news about myopic macular degeneration?

Speaker: Dr Annegret Dahlmann-Noor, consultant ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust.

Description: Dr Annegret Dahlmann-Noor shares the latest research on myopic macular degeneration, including current treatments and future developments.

Investigating the genetics of RPGR-associated cone dystrophy

Speaker: Cristina Martinez, research associate at the University of Oxford.

Description: Cristina Martinez shares insights on investigating the genetics of RPGR-associated cone dystrophy.

Stargardt disease: overview and treatment horizon

Speaker: Dr Kenneth Fan, Retina Consultants of Texas.

Description: Dr Kenneth Fan shares an overview of Stargardt disease, including current and future research and treatments.

Demystifying assistive technology for work and home

Speakers: Iain Kennedy, partnerships and development manager and Stuart Lawler, head of digital content at Sight and Sound Technology.

Description: Iain Kennedy and Stuart Lawler share insights and developments in the field to help better understand the potential of assistive technology.

More from the Macular Disease Conference 2025

Catch up on other sessions from the day:

Macular Disease Conference 2025 logo with conference speakers

Back to Macular Disease Conference 2025

The 2025 Macular Disease Conference took place online on Saturday 13 September. Experts, researchers, and people affected by macular disease came together for a day of learning, support, and hope for the future.